Uveal Diseases

01/01/1994 - "The uveal disease was characterized by acute, granulomatous or nongranulomatous anterior uveal involvement and granular or membranous vitreous opacities with or without retinal vascular change. "
12/01/1956 - "Retinal lesions associated with uveal disease. "
08/01/1970 - "[Dynamics of plasma kinin in eye diseases and effects of anti-kinin agents with special reference to retinal and uveal diseases]."
10/01/2010 - "For example, the secondary sampling epidemiologic study of disabled persons in China in 2006 showed that the major causes of blindness and vision impairment were cataract (56.7%), retinal and uveal diseases (14.1%) and corneal diseases (10.3%). "
02/01/1998 - "Latanoprost should be used with caution in pseudophakic and aphakic patients--especially those with retinal vascular fragility, any inflammatory uveal disease, or other factors that may predispose to the breakdown of the blood-retinal barrier."

01/01/1994 - "1) middle-aged adult of either sex develops acute, inflammatory uveal disease and presents with visual haze or floaters, or both; 2) active disease consists of granulomatous or nongranulomatous reactions accompanied by vitreous opacities and retinal vasculitis with rare retinochoroidal exudative changes; 3) the disease resolves with response to corticosteroids, although leaving sequelae in occasional cases; 4) the disease affects one or both eyes, and up to half of cases show recurrent disease within years; 5) the visual outcome is usually favorable; 6) the disease occurs as an isolated disorder, but may sometimes be complicated by HTLV-I associated myelopathy. "
09/01/1994 - "Assuming that a collection of 50 cases of HTLV-I seropositive, etiology-undefined uveitis represents HAU, its clinical features consisted were: (1) middle-aged, otherwise healthy adults developed acute inflammatory uveal disease and presented with visual haze and/or floaters; (2) the disease showed granulomatous or nongranulomatous anterior uveal reactions accompanied by vitreous opacities and retinal vasculitis; (3) the lesions resolved in response to topical or systemic corticosteroids; (4) the visual outcome was usually favorable; (5) nearly half of the cases had recurrent disease; (6) the cases remained systemically unremarkable, except for two cases of HTLV-I associated myelopathy and eight cases of hyper thyroid disease."

01/01/1985 - "The relationship of retinal S-antigen to other cell components in the retina and the possible mechanisms of the autoimmune uveal diseases are discussed."

01/01/1997 - "Cytokines: their role in uveal disease."

02/01/1966 - "Methotrexate treatment of uveal disease."

01/01/1922 - "Concerning the Use of Diphtheria Antitoxin in Post-Operative Infections and Acute Uveal Disease."

01/01/1957 - "[Post-traumatic uveal disease with cholesterol crystals: ocular xanthomatosis]."

01/01/1994 - "All of the patients had serum antibodies to HTLV-I. The uveal disease resembled HTLV-I associated uveitis that may develop in patients with HTLV-I associated myelopathy or HTLV-I carriers; 2 cases had chronic myelopathy or arthropathy that was considered associated with the retrovirus. "

04/01/1988 - "Acyclovir seems to be a promising adjunct antiviral agent for the treatment of recalcitrant epithelial, stromal, or uveal disease secondary to HSV."

02/01/1998 - "Latanoprost should be used with caution in pseudophakic and aphakic patients--especially those with retinal vascular fragility, any inflammatory uveal disease, or other factors that may predispose to the breakdown of the blood-retinal barrier."

01/01/2010 - "Until recently chemotherapy was used as adjuvant therapy after enucleation in cases with extraretinal spread of the disease (uveal extension, orbital extension, neoplastic infiltrates of the optic nerve at resection line, intracranial metastasis, generalized disease). "